Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT - Nasdaq - US50101L1061 - Common Stock - Currency: USD

2.67  0 (0%)

After market: 2.7 +0.03 (+1.12%)

Fundamental Rating

2

Taking everything into account, DNUT scores 2 out of 10 in our fundamental rating. DNUT was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. DNUT has a bad profitability rating. Also its financial health evaluation is rather negative. DNUT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DNUT has reported negative net income.
In the past year DNUT had a positive cash flow from operations.
In the past 5 years DNUT reported 4 times negative net income.
DNUT had a positive operating cash flow in each of the past 5 years.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.70%, DNUT is doing worse than 66.42% of the companies in the same industry.
The Return On Equity of DNUT (-1.97%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.7%
ROE -1.97%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

DNUT has a Gross Margin of 30.78%. This is in the lower half of the industry: DNUT underperforms 76.87% of its industry peers.
In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DNUT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DNUT has more shares outstanding
The number of shares outstanding for DNUT has been increased compared to 5 years ago.
The debt/assets ratio for DNUT is higher compared to a year ago.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DNUT (0.34) is worse than 80.60% of its industry peers.
DNUT has a Debt/Equity ratio of 0.85. This is a neutral value indicating DNUT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.85, DNUT is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACCN/A
WACC6.85%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

DNUT has a Current Ratio of 0.35. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.35, DNUT is doing worse than 85.07% of the companies in the same industry.
DNUT has a Quick Ratio of 0.35. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DNUT (0.28) is worse than 84.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.28
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for DNUT have decreased strongly by -100.00% in the last year.
Looking at the last year, DNUT shows a decrease in Revenue. The Revenue has decreased by -6.55% in the last year.
The Revenue has been growing by 11.66% on average over the past years. This is quite good.
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
Revenue 1Y (TTM)-6.55%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-15.25%

3.2 Future

Based on estimates for the next years, DNUT will show a small growth in Earnings Per Share. The EPS will grow by 2.04% on average per year.
The Revenue is expected to decrease by -2.91% on average over the next years.
EPS Next Y-177.21%
EPS Next 2Y-68.06%
EPS Next 3Y2.04%
EPS Next 5YN/A
Revenue Next Year-7.96%
Revenue Next 2Y-2.73%
Revenue Next 3Y-2.91%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DNUT is valuated quite expensively with a Price/Forward Earnings ratio of 218.14.
DNUT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DNUT is more expensive than 70.15% of the companies in the same industry.
DNUT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.03.
Industry RankSector Rank
PE N/A
Fwd PE 218.14
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DNUT indicates a slightly more expensive valuation: DNUT is more expensive than 61.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.04
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.06%
EPS Next 3Y2.04%

More info and screens

5

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 5.24%, which is a nice return.
The stock price of DNUT dropped by -51.45% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
DNUT's Dividend Yield is rather good when compared to the industry average which is at 3.70. DNUT pays more dividend than 93.28% of the companies in the same industry.
DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 5.24%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-136.93%
EPS Next 2Y-68.06%
EPS Next 3Y2.04%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

More info and screens

KRISPY KREME INC

NASDAQ:DNUT (6/20/2025, 8:00:02 PM)

After market: 2.7 +0.03 (+1.12%)

2.67

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners52.82%
Inst Owner Change-4.44%
Ins Owners2.62%
Ins Owner Change0.5%
Market Cap456.04M
Analysts73.33
Price Target7.28 (172.66%)
Short Float %32.15%
Short Ratio5.13
Dividend
Industry RankSector Rank
Dividend Yield 5.24%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-136.93%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-45.6%
Min EPS beat(2)-89.88%
Max EPS beat(2)-1.32%
EPS beat(4)0
Avg EPS beat(4)-71.43%
Min EPS beat(4)-192.23%
Max EPS beat(4)-1.32%
EPS beat(8)2
Avg EPS beat(8)-43.93%
EPS beat(12)4
Avg EPS beat(12)-31.12%
EPS beat(16)5
Avg EPS beat(16)-23.81%
Revenue beat(2)0
Avg Revenue beat(2)-4.48%
Min Revenue beat(2)-4.66%
Max Revenue beat(2)-4.3%
Revenue beat(4)0
Avg Revenue beat(4)-3.06%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.21%
Revenue beat(8)1
Avg Revenue beat(8)-2.19%
Revenue beat(12)4
Avg Revenue beat(12)-1.43%
Revenue beat(16)5
Avg Revenue beat(16)-0.99%
PT rev (1m)-28.22%
PT rev (3m)-39.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1076.33%
EPS NY rev (1m)-10.58%
EPS NY rev (3m)-130.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.33%
Revenue NY rev (1m)-2.06%
Revenue NY rev (3m)-6.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 218.14
P/S 0.29
P/FCF N/A
P/OCF 10.68
P/B 0.41
P/tB N/A
EV/EBITDA 16.04
EPS(TTM)0
EYN/A
EPS(NY)0.01
Fwd EY0.46%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.25
OCFY9.36%
SpS9.36
BVpS6.45
TBVpS-4.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -1.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.78%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA 10.51
Cap/Depr 87.84%
Cap/Sales 7.36%
Interest Coverage N/A
Cash Conversion 48%
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.28
Altman-Z 0.34
F-Score4
WACC6.85%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
EPS Next Y-177.21%
EPS Next 2Y-68.06%
EPS Next 3Y2.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.55%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-15.25%
Revenue Next Year-7.96%
Revenue Next 2Y-2.73%
Revenue Next 3Y-2.91%
Revenue Next 5YN/A
EBIT growth 1Y-518.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year538.31%
EBIT Next 3Y101.17%
EBIT Next 5YN/A
FCF growth 1Y-676.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.94%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%